IHME reported global diabetes cases to soar from 529 million to 1.3 billion by 2050
On Jun. 22, 2023, the Institute for Health Metrics and Evaluation (IHME) reported that more than half a…
Biotechnology | Disease | FDA | Medicine | Therapeutics
U.S. FDA approved first gene therapy for treatment of patients with Duchenne Muscular Dystrophy
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
Donald Triplett, the 1st person diagnosed with autism, died at 89
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
Milestones in Parkinson’s
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
Disease | FDA | Pharmaceutical | Therapeutics | Vaccine
U.S. FDA approved ABRYSVO, Pfizer’s vaccine for prevention of RSV in older adults
On May 31, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
FDA approved first topical gene therapy for treatment of wounds in patients with dystrophic epidermolysis bullosa
On May 19, 2023, the U.S. Food and Drug Administration (FDA) approved Krystal Biotech’s Vyjuvek, a herpes-simplex virus…
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA approved first drug to treat agitation symptoms associated with dementia due to Alzheimer’s disease
On May 11, 2023, the U.S. Food and Drug Administration (FDA) announced the supplemental approval of Otsuka Pharmaceutical…
U.S. Preventive Services Task Force recommended that all women get screened for breast cancer every other year starting at age 40
On May 9, 2023, the U.S. Preventive Services Task Force (USPSTF) recommended that all women get screened for…
Biotechnology | Disease | NIH | Therapeutics
NIH researchers uncovered new details on rare immune disease
On May 3, 2023, National Institutes of Health (NIH) scientists announced that they had uncovered new details on…
Oregon Health Sciences University dermatologists detected the world’s smallest skin cancer
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
Genomes from 240 mammalian species revealed what makes the human genome unique
On Apr. 27, 2023, the Zoonomia Project team announced in in a special issue of Science, that had…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
U.S. Preventive Services Task Force issued recommendation on screening for skin cancer
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
Biotechnology | CRISPR | Diagnostics | Disease | Genomics | Therapeutics
Jennifer Doudna and Jill Banfield to lead $70 million initiative to edit the microbiome
On Apr. 17, 2023, a new initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics…
Parkinson’s disease biomarker found
On Apr. 13, 2023, in an enormous leap forward in the understanding of Parkinson’s disease (PD), researchers announced…
Biotechnology | Disease | HIV | NIH | Non-Profit Research
Daily statin reduced the risk of cardiovascular disease in people living with HIV, large NIH study found
On Apr. 11, 2023, a National Institutes of Health (NIH) clinical trial was stopped early because a daily…
Highly pathogenic avian influenza confirmed as cause of three California condor mortalities in Arizona
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA updated mammography regulations to require reporting of breast density information and facility oversight
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
British Columbia Institute of Technology received $14.5 million to support aerospace and life sciences training
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics | WHO | Women's Health
WHO launched new roadmap on breast cancer
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
Biotechnology | Disease | NIH | Therapeutics | Vaccine
Experimental NIH Sudan virus vaccine protected Macaques
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
A 19-Year-Old Adolescent with Probable Alzheimer’s Disease
On Jan. 31, 2023, a team of researchers led by the Innovation Center for Neurological Disorders and Department…
Risk of developing heart failure much higher in rural areas vs. urban
On Jan. 25, 2023, it was reported that adults living in rural areas of the United States have…
Biotechnology | Cartoons - Original | CRISPR | Disease | Genomics | Life Science History | Therapeutics
Milestones in CRISPR
Our Milestones in CRISPR cartoon illustrates several significant achievements in the development of the technology with commentary by…
Uganda declared end of Ebola disease outbreak
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
Biotechnology | Diagnostics | Disease | FDA | Neurology | Therapeutics
FDA granted accelerated approval for Alzheimer’s disease treatment
On Jan. 6, 2023, the U.S. Food and Drug Administration (FDA) approved Leqembi (lecanemab-irmb) via the Accelerated Approval…
Biotechnology | CRISPR | Disease | Prehistory | Therapeutics
2.6 billion-year-old ancestors of the CRISPR gene-editing tool were resurrected
On Jan. 4, 2023, an international research group announced it had for the first time reconstructed ancestors dating…
Biotechnology | Cartoons - Original | Disease | Life Science History | Polio | Therapeutics | Vaccine
Milestones in Polio
Milestones in Polio illustrates the slow but steady advancements from its clinical description and discovery to widespread infection…
CSL’s Novel Gene Therapy HEMGENIX® (etranacogene dezaparvovec-drlb) Demonstrated Durable Protection and Sustained Factor IX Activity Levels for People Living with Hemophilia B
On Dec. 10, 2022, CSL announced data affirming the long-term durability and safety of single-infusion HEMGENIX® (etranacogene dezaparvovec-drlb)…
FDA approved first gene therapy to treat adults with Hemophilia B
On Nov. 22, 2022, the U.S. Food and Drug Administration approved the investigational gene therapy etranacogene dezaparvovec or…
Biotechnology | Disease | FDA | Therapeutics
FDA approved first drug that can delay onset of Type 1 Diabetes
On Nov. 17, 2022, the U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) injection to delay the…